News
Media
Conferences
Publications
Events
CME/CE
Resources
Career Center
Subscribe

Your AI-Trained Oncology Knowledge Connection!

Nina Oestreicher

Articles by Nina Oestreicher

24 Real-world Use of Neratinib Post-Pertuzumab (P) and –Ado-Trastuzumab Emtansine (T-DM1)

ByKathryn Martin,Hope Rugo, MD,Gregory Vidal, MD, PhD,Nina Oestreicher,Deepa Lalla,Gillian Hanson,Daniel Drozd,Kristie Traverso,Dan DiPrimeo,Debu Tripathy, MD

Published: April 18th 2022 | Updated: April 19th 2022

Latest Updated Articles

24 Real-world Use of Neratinib Post-Pertuzumab (P) and –Ado-Trastuzumab Emtansine (T-DM1)
Published: April 18th 2022 | Updated: April 19th 2022

Trending on CancerNetwork

FDA Grants Accelerated Approval to Zongertinib in HER2+ NSCLC

Iza-Bren Yields Statistically Significant Efficacy in Advanced TNBC

Decoding Key Community Oncology Takeaways From ASCO GI 2026

Developer Terminates DHX9 Inhibitor Trial Amid Safety Concerns

How has Immunotherapy Evolved in Breast Cancer Treatment?